Literature DB >> 9114728

A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes.

J C Frölich1.   

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) are, as a group, the most frequently consumed drugs worldwide. They also cause the most, and often dangerous, side-effects reported to the US Food and Drug Administration, the majority of which are owing to damage of the gastrointestinal tract and kidneys. This explains the continuous interest of pharmacologists, clinical pharmacologists and pharmacoepidemiologists in this group of drugs. Based on an increasing body of data, J. Frölich proposes a simple alternative to the usual chemical classification of NSAIDs, allowing one to predict a drug's major effects according to its relative inhibition of the constitutive and inducible cyclooxygenase isoenzymes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9114728     DOI: 10.1016/s0165-6147(96)01017-6

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  30 in total

Review 1.  [A synopsis of medication for degenerative osteoarthritis].

Authors:  J Grifka; U Müller-Ladner
Journal:  Orthopade       Date:  2004-07       Impact factor: 1.087

2.  Correspondence (letter to the editor): Some Additional Comments.

Authors:  Dirk O Stichtenoth
Journal:  Dtsch Arztebl Int       Date:  2008-05-16       Impact factor: 5.594

Review 3.  The second generation of COX-2 inhibitors: what advantages do the newest offer?

Authors:  Dirk O Stichtenoth; Jürgen C Frölich
Journal:  Drugs       Date:  2003       Impact factor: 9.546

4.  Involvement of endothelial thromboxane A2 in the vasoconstrictor response induced by 15-E2t-isoprostane in isolated human umbilical vein.

Authors:  Federico Manuel Daray; Julia Renata Colombo; Julián Rodríguez Kibrik; Andrea Emilse Errasti; Facundo Germán Pelorosso; Wanda Nowak; Jean-Luc Cracowski; Rodolfo Pedro Rothlin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-08       Impact factor: 3.000

5.  Expression of cyclooxygenase enzymes in rat hypothalamo-pituitary-adrenal axis: effects of endotoxin and glucocorticoids.

Authors:  P O Cover; D Slater; J C Buckingham
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

Review 6.  [New non-steroidal anti-rheumatic drugs: selective inhibitors of inducible cyclooxygenase].

Authors:  D O Stichtenoth; H Zeidler; J C Frölich
Journal:  Med Klin (Munich)       Date:  1998-07-15

7.  Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia.

Authors:  M Nakayama; K Uchimura; R L Zhu; T Nagayama; M E Rose; R A Stetler; P C Isakson; J Chen; S H Graham
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

Review 8.  Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options?

Authors:  M Ostensen; R Ramsey-Goldman
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

9.  Genome-wide RNA interference screening reveals a COPI-MAP2K3 pathway required for YAP regulation.

Authors:  Yong Joon Kim; Eunji Jung; Eunbie Shin; Sin-Hyoung Hong; Hui Su Jeong; Gayeong Hur; Hye Yun Jeong; Seung-Hyo Lee; Ji Eun Lee; Gun-Hwa Kim; Joon Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-03       Impact factor: 11.205

10.  Aspirin resistance.

Authors:  Khaled Mansour; Ali T Taher; Khaled M Musallam; Samir Alam
Journal:  Adv Hematol       Date:  2009-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.